Бизнес · 21.09.20201 мин чтения
Investigational COVID-19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA or Agency) is announcing the withdrawal of a final guidance for industry entitled "Investigational COVID-19 Convalescent Plasma," which was issued in April 2020 and updated in May 2020. FDA is withdrawing the guidance because the Agency is issuing a new guidance for industry of the same title.